BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berindan-Neagoe I, Monroig Pdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64:311-336. [PMID: 25104502 DOI: 10.3322/caac.21244] [Cited by in Crossref: 303] [Cited by in F6Publishing: 301] [Article Influence: 37.9] [Reference Citation Analysis]
Number Citing Articles
1 Kricka LJ, Wilson RB. RNA Testing Now Automated. Clinical Chemistry 2015;61:571-2. [DOI: 10.1373/clinchem.2014.237594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Dou Y, Wang W, Tang Y. Clinical significance of expression of miR-145 in gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(35): 5683-5687 [DOI: 10.11569/wcjd.v23.i35.5683] [Reference Citation Analysis]
3 Khan P, Ebenezer NS, Siddiqui JA, Maurya SK, Lakshmanan I, Salgia R, Batra SK, Nasser MW. MicroRNA-1: Diverse role of a small player in multiple cancers. Semin Cell Dev Biol 2021:S1084-9521(21)00129-4. [PMID: 34034986 DOI: 10.1016/j.semcdb.2021.05.020] [Reference Citation Analysis]
4 Ma DH, Li BS, Liu JJ, Xiao YF, Yong X, Wang SM, Wu YY, Zhu HB, Wang DX, Yang SM. miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway. Cancer Lett 2017;408:23-32. [PMID: 28842285 DOI: 10.1016/j.canlet.2017.08.017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 8.4] [Reference Citation Analysis]
5 Ciocan-Cartita CA, Jurj A, Buse M, Gulei D, Braicu C, Raduly L, Cojocneanu R, Pruteanu LL, Iuga CA, Coza O, Berindan-Neagoe I. The Relevance of Mass Spectrometry Analysis for Personalized Medicine through Its Successful Application in Cancer "Omics". Int J Mol Sci 2019;20:E2576. [PMID: 31130665 DOI: 10.3390/ijms20102576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
6 Zhang ZY, Li YC, Geng CY, Wang HJ, Chen WM. Potential Relationship between Clinical Significance and Serum Exosomal miRNAs in Patients with Multiple Myeloma. Biomed Res Int 2019;2019:1575468. [PMID: 31915680 DOI: 10.1155/2019/1575468] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
7 Ramalho-Carvalho J, Martins JB, Cekaite L, Sveen A, Torres-Ferreira J, Graça I, Costa-Pinheiro P, Eilertsen IA, Antunes L, Oliveira J, Lothe RA, Henrique R, Jerónimo C. Epigenetic disruption of miR-130a promotes prostate cancer by targeting SEC23B and DEPDC1. Cancer Lett 2017;385:150-9. [PMID: 27984115 DOI: 10.1016/j.canlet.2016.10.028] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 5.2] [Reference Citation Analysis]
8 Li Y, Li G, Guo X, Yao H, Wang G, Li C. Non-coding RNA in bladder cancer. Cancer Lett 2020;485:38-44. [PMID: 32437725 DOI: 10.1016/j.canlet.2020.04.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
9 Konoshenko MY, Lekchnov EA, Bryzgunova OE, Zaporozhchenko IA, Yarmoschuk SV, Pashkovskaya OA, Pak SV, Laktionov PP. The Panel of 12 Cell-Free MicroRNAs as Potential Biomarkers in Prostate Neoplasms. Diagnostics (Basel) 2020;10:E38. [PMID: 31936850 DOI: 10.3390/diagnostics10010038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
10 Yan T, Wu M, Lv S, Hu Q, Xu W, Zeng A, Huang K, Zhu X. Exosomes derived from microRNA-512-5p-transfected bone mesenchymal stem cells inhibit glioblastoma progression by targeting JAG1. Aging (Albany NY) 2021;13:9911-26. [PMID: 33795521 DOI: 10.18632/aging.202747] [Reference Citation Analysis]
11 Favier A, Rocher G, Larsen AK, Delangle R, Uzan C, Sabbah M, Castela M, Duval A, Mehats C, Canlorbe G. MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review. Cancers (Basel) 2021;13:1137. [PMID: 33800944 DOI: 10.3390/cancers13051137] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ferro M, La Civita E, Liotti A, Cennamo M, Tortora F, Buonerba C, Crocetto F, Lucarelli G, Busetto GM, Del Giudice F, de Cobelli O, Carrieri G, Porreca A, Cimmino A, Terracciano D. Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer. J Pers Med 2021;11:237. [PMID: 33806972 DOI: 10.3390/jpm11030237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Xiong DD, Xu WQ, He RQ, Dang YW, Chen G, Luo DZ. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme. Oncol Rep 2019;41:2194-208. [PMID: 30816530 DOI: 10.3892/or.2019.7022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
14 Jiang W, Wei K, Pan C, Li H, Cao J, Han X, Tang Y, Zhu S, Yuan W, He Y, Xia Y, Chen L, Chen Y. MicroRNA-1258 suppresses tumour progression via GRB2/Ras/Erk pathway in non-small-cell lung cancer. Cell Prolif 2018;51:e12502. [PMID: 30069987 DOI: 10.1111/cpr.12502] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
15 Ma J, Li D, Kong FF, Yang D, Yang H, Ma XX. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development. J Exp Clin Cancer Res 2018;37:19. [PMID: 29391048 DOI: 10.1186/s13046-018-0686-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
16 Yang C, Mou Z, Zhang Z, Wu S, Zhou Q, Chen Y, Gong J, Xu C, Ou Y, Chen X, Dai X, Jiang H. Circular RNA RBPMS inhibits bladder cancer progression via miR-330-3p/RAI2 regulation. Mol Ther Nucleic Acids 2021;23:872-86. [PMID: 33614236 DOI: 10.1016/j.omtn.2021.01.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Zheng H, Yan B, Wu Q, Zhang J. MicroRNA-9-5p increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating high mobility group A2 expression. Oncol Lett 2021;21:235. [PMID: 33613724 DOI: 10.3892/ol.2021.12496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li Z, Liu Z, Dong S, Zhang J, Tan J, Wang Y, Ge C, Li R, Xue Y, Li M, Wang W, Xiang X, Yang J, Ding H, Geng T, Yao K, Song X. miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer. Am J Pathol 2015;185:2412-20. [PMID: 26362716 DOI: 10.1016/j.ajpath.2015.05.017] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
19 Jiang J, Jia Z, Cao D, Wu Y, Sun Z, Cao X. Association of the miR-146a rs2910164 polymorphism with gastric cancer susceptibility and prognosis. Future Oncology 2016;12:2215-26. [DOI: 10.2217/fon-2016-0224] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
20 Chen L, Zhang X, Wang S, Lin X, Xu L. Circ_0084927 Facilitates Cervical Cancer Development via Sponging miR-142-3p and Upregulating ARL2.Cancer Manag Res. 2020;12:9271-9283. [PMID: 33061617 DOI: 10.2147/CMAR.S263596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Li Z, Jiang L, Zhao R, Huang J, Yang W, Wen Z, Zhang B, Du G. MiRNA-based model for predicting the TMB level in colon adenocarcinoma based on a LASSO logistic regression method. Medicine (Baltimore) 2021;100:e26068. [PMID: 34032736 DOI: 10.1097/MD.0000000000026068] [Reference Citation Analysis]
22 Irimie AI, Braicu C, Sonea L, Zimta AA, Cojocneanu-Petric R, Tonchev K, Mehterov N, Diudea D, Buduru S, Berindan-Neagoe I. A Looking-Glass of Non-coding RNAs in oral cancer. Int J Mol Sci 2017;18:E2620. [PMID: 29206174 DOI: 10.3390/ijms18122620] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
23 Zhang X, Li X, Fu X, Yu M, Qin G, Chen G, Huang C. Circular RNA TAF4B Promotes Bladder Cancer Progression by Sponging miR-1298-5p and Regulating TGFA Expression. Front Oncol 2021;11:643362. [PMID: 34322376 DOI: 10.3389/fonc.2021.643362] [Reference Citation Analysis]
24 Liu Q, Peng F, Chen J. The Role of Exosomal MicroRNAs in the Tumor Microenvironment of Breast Cancer. Int J Mol Sci. 2019;20. [PMID: 31395836 DOI: 10.3390/ijms20163884] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
25 Jiang Y, He J, Li Y, Guo Y, Tao H. The Diagnostic Value of MicroRNAs as a Biomarker for Hepatocellular Carcinoma: A Meta-Analysis. Biomed Res Int 2019;2019:5179048. [PMID: 31871941 DOI: 10.1155/2019/5179048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
26 Cheng J, Chen Y, Zhao P, Li N, Lu J, Li J, Liu Z, Lv Y, Huang C. Dysregulation of miR-638 in hepatocellular carcinoma and its clinical significance. Oncol Lett 2017;13:3859-65. [PMID: 28529597 DOI: 10.3892/ol.2017.5882] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
27 Wang J, Zhang X, Yao H, Le Y, Zhou W, Li J, Lu L, Chen M, Li X. MiR-490-5p functions as tumor suppressor in childhood neuroblastoma by targeting MYEOV. Human Cell 2020;33:261-71. [DOI: 10.1007/s13577-019-00302-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
28 Satyal U, Srivastava A, Abbosh PH. Urine Biopsy-Liquid Gold for Molecular Detection and Surveillance of Bladder Cancer. Front Oncol 2019;9:1266. [PMID: 31803629 DOI: 10.3389/fonc.2019.01266] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
29 Rui T, Xu S, Zhang X, Huang H, Feng S, Zhan S, Xie H, Zhou L, Ling Q, Zheng S. The chromosome 19 microRNA cluster, regulated by promoter hypomethylation, is associated with tumour burden and poor prognosis in patients with hepatocellular carcinoma. J Cell Physiol 2020;235:6103-12. [PMID: 31975381 DOI: 10.1002/jcp.29538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
30 Xie K, Chen M, Zhu M, Wang C, Qin N, Liang C, Song C, Dai J, Jin G, Shen H, Lin D, Ma H, Hu Z. A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in Chinese population. Int J Cancer. 2017;141:958-966. [PMID: 28510306 DOI: 10.1002/ijc.30788] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
31 Gambari R, Brognara E, Spandidos DA, Fabbri E. Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review). Int J Oncol 2016;49:5-32. [PMID: 27175518 DOI: 10.3892/ijo.2016.3503] [Cited by in Crossref: 108] [Cited by in F6Publishing: 114] [Article Influence: 18.0] [Reference Citation Analysis]
32 Dutkowska A, Szmyd B, Kaszkowiak M, Domańska-Senderowska D, Pastuszak-Lewandoska D, Brzeziańska-Lasota E, Kordiak J, Antczak A. Expression of inflammatory interleukins and selected miRNAs in non-small cell lung cancer. Sci Rep 2021;11:5092. [PMID: 33658555 DOI: 10.1038/s41598-021-84408-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Liang W, Liao Y, Li Z, Wang Y, Zheng S, Xu X, Ran F, Tang B, Wang Z. MicroRNA-644a promotes apoptosis of hepatocellular carcinoma cells by downregulating the expression of heat shock factor 1. Cell Commun Signal 2018;16:30. [PMID: 29898735 DOI: 10.1186/s12964-018-0244-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Tang Y, Zhang Z, Song X, Yu M, Niu L, Zhao Y, Wang L, Song X, Xie L. Tumor-Derived Exosomal miR-620 as a Diagnostic Biomarker in Non-Small-Cell Lung Cancer. J Oncol 2020;2020:6691211. [PMID: 33343663 DOI: 10.1155/2020/6691211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
35 Penyige A, Márton É, Soltész B, Szilágyi-Bónizs M, Póka R, Lukács J, Széles L, Nagy B. Circulating miRNA Profiling in Plasma Samples of Ovarian Cancer Patients. Int J Mol Sci 2019;20:E4533. [PMID: 31540229 DOI: 10.3390/ijms20184533] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
36 Rui T, Zhang X, Feng S, Huang H, Zhan S, Xie H, Zhou L, Ling Q, Zheng S. The Similar Effects of miR-512-3p and miR-519a-2-5p on the Promotion of Hepatocellular Carcinoma: Different Tunes Sung With Equal Skill. Front Oncol 2020;10:1244. [PMID: 32850377 DOI: 10.3389/fonc.2020.01244] [Reference Citation Analysis]
37 Su S, Shao J, Zhao Q, Ren X, Cai W, Li L, Bai Q, Chen X, Xu B, Wang J, Cao J, Zang W. MiR-30b Attenuates Neuropathic Pain by Regulating Voltage-Gated Sodium Channel Nav1.3 in Rats. Front Mol Neurosci 2017;10:126. [PMID: 28529474 DOI: 10.3389/fnmol.2017.00126] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 9.2] [Reference Citation Analysis]
38 Yang L, Li L, Ma J, Yang S, Zou C, Yu X. miRNA and mRNA Integration Network Construction Reveals Novel Key Regulators in Left-Sided and Right-Sided Colon Adenocarcinoma. Biomed Res Int 2019;2019:7149296. [PMID: 31073530 DOI: 10.1155/2019/7149296] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
39 Lin Y, Zhu S, Hu C, Wang J, Jiang P, Zhu L, Li Z, Wang S, Zhang Y, Xu X, Pan W. Cross-Species Suppression of Hepatoma Cell Growth and Migration by a Schistosoma japonicum MicroRNA. Mol Ther Nucleic Acids 2019;18:400-12. [PMID: 31655260 DOI: 10.1016/j.omtn.2019.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
40 Deng X, Yin Z, Lu J, Li X, Shao L, Zhao C, Yang Y, Hu Q, Wu Y, Sheng W. In Situ Monitoring of MicroRNA Replacement Efficacy and Accurate Imaging-Guided Cancer Therapy through Light-Up Inter-Polyelectrolyte Nanocomplexes. Adv Sci (Weinh) 2018;5:1700542. [PMID: 29721409 DOI: 10.1002/advs.201700542] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
41 Wei Y, Niu B. Role of MALAT1 as a Prognostic Factor for Survival in Various Cancers: A Systematic Review of the Literature with Meta-Analysis. Dis Markers 2015;2015:164635. [PMID: 26420912 DOI: 10.1155/2015/164635] [Cited by in Crossref: 25] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
42 Xu X, Chen X, Xu M, Liu X, Pan B, Qin J, Xu T, Zeng K, Pan Y, He B, Sun H, Sun L, Wang S. miR-375-3p suppresses tumorigenesis and partially reverses chemoresistance by targeting YAP1 and SP1 in colorectal cancer cells. Aging (Albany NY). 2019;11:7357-7385. [PMID: 31543507 DOI: 10.18632/aging.102214] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
43 Emmrich S, Engeland F, El-Khatib M, Henke K, Obulkasim A, Schöning J, Katsman-Kuipers JE, Michel Zwaan C, Pich A, Stary J, Baruchel A, de Haas V, Reinhardt D, Fornerod M, van den Heuvel-Eibrink MM, Klusmann JH. miR-139-5p controls translation in myeloid leukemia through EIF4G2. Oncogene 2016;35:1822-31. [PMID: 26165837 DOI: 10.1038/onc.2015.247] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
44 Li G, Han L, Ren F, Zhang R, Qin G. Prognostic value of the tumor-specific ceRNA network in epithelial ovarian cancer. J Cell Physiol 2019;234:22071-81. [PMID: 31152442 DOI: 10.1002/jcp.28770] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
45 Budisan L, Gulei D, Zanoaga OM, Irimie AI, Sergiu C, Braicu C, Gherman CD, Berindan-Neagoe I. Dietary Intervention by Phytochemicals and Their Role in Modulating Coding and Non-Coding Genes in Cancer. Int J Mol Sci 2017;18:E1178. [PMID: 28587155 DOI: 10.3390/ijms18061178] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 9.2] [Reference Citation Analysis]
46 Gan H, Lin L, Hu N, Yang Y, Gao Y, Pei Y, Chen K, Sun B. Aspirin ameliorates lung cancer by targeting the miR-98/WNT1 axis. Thorac Cancer 2019;10:744-50. [PMID: 30756509 DOI: 10.1111/1759-7714.12992] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Manikkath J, Jishnu PV, Wich PR, Manikkath A, Radhakrishnan R. Nanoparticulate strategies for the delivery of miRNA mimics and inhibitors in anticancer therapy and its potential utility in oral submucous fibrosis. Nanomedicine (Lond) 2022. [PMID: 35014880 DOI: 10.2217/nnm-2021-0381] [Reference Citation Analysis]
48 Li F, Liang J, Bai L. MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression. Biomedicine & Pharmacotherapy 2018;103:782-9. [DOI: 10.1016/j.biopha.2018.04.101] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
49 Moazeni-Roodi A, Ghavami S, Hashemi M. Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies. Microrna 2019;8:94-100. [PMID: 30514199 DOI: 10.2174/2211536608666181204110508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
50 El-Hamouly MS, Azzam AA, Ghanem SE, El-Bassal FI, Shebl N, Shehata AMF. Circulating microRNA-301 as a promising diagnostic biomarker of hepatitis C virus-related hepatocellular carcinoma. Mol Biol Rep 2019;46:5759-65. [PMID: 31471732 DOI: 10.1007/s11033-019-05009-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
51 Li SC, Monazzam A, Razmara M, Chu X, Stålberg P, Skogseid B. MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines. Sci Rep 2021;11:14772. [PMID: 34285285 DOI: 10.1038/s41598-021-94154-z] [Reference Citation Analysis]
52 Cao Z, Qiu J, Yang G, Liu Y, Luo W, You L, Zheng L, Zhang T. MiR-135a biogenesis and regulation in malignancy: a new hope for cancer research and therapy. Cancer Biol Med 2020;17:569-82. [PMID: 32944391 DOI: 10.20892/j.issn.2095-3941.2020.0033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
53 Wang F, Ma Y, Wang H, Qin H. Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer. Oncol Lett 2017;13:1048-57. [PMID: 28454212 DOI: 10.3892/ol.2017.5593] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
54 Zhang WC, Chin TM, Yang H, Nga ME, Lunny DP, Lim EK, Sun LL, Pang YH, Leow YN, Malusay SR, Lim PX, Lee JZ, Tan BJ, Shyh-Chang N, Lim EH, Lim WT, Tan DS, Tan EH, Tai BC, Soo RA, Tam WL, Lim B. Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression. Nat Commun. 2016;7:11702. [PMID: 27325363 DOI: 10.1038/ncomms11702] [Cited by in Crossref: 92] [Cited by in F6Publishing: 102] [Article Influence: 15.3] [Reference Citation Analysis]
55 Yang X, Liu H, Zhang Q, Liu K, Yu D, Zhang Y, Shi Z. MiR-96 promotes apoptosis of nucleus pulpous cells by targeting FRS2. Hum Cell 2020;33:1017-25. [PMID: 32578051 DOI: 10.1007/s13577-020-00389-9] [Reference Citation Analysis]
56 Liu F, Tian T, Xia LL, Ding Y, Cormier RT, He Y. Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update. Dis Esophagus 2017;30:1-9. [PMID: 27003597 DOI: 10.1111/dote.12489] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
57 Buduru S, Zimta AA, Ciocan C, Braicu C, Dudea D, Irimie AI, Berindan-Neagoe I. RNA interference: new mechanistic and biochemical insights with application in oral cancer therapy. Int J Nanomedicine 2018;13:3397-409. [PMID: 29922059 DOI: 10.2147/IJN.S167383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
58 Holubekova V, Mendelova A, Jasek K, Mersakova S, Zubor P, Lasabova Z. Epigenetic regulation by DNA methylation and miRNA molecules in cancer. Future Oncology 2017;13:2217-22. [DOI: 10.2217/fon-2017-0363] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
59 Zhang H, Liu A, Feng X, Tian L, Bo W, Wang H, Hu Y. MiR-132 promotes the proliferation, invasion and migration of human pancreatic carcinoma by inhibition of the tumor suppressor gene PTEN. Prog Biophys Mol Biol 2019;148:65-72. [PMID: 28941804 DOI: 10.1016/j.pbiomolbio.2017.09.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
60 Yang X, Zhu X, Yan Z, Li C, Zhao H, Ma L, Zhang D, Liu J, Liu Z, Du N, Ye Q, Xu X. miR-489-3p/SIX1 Axis Regulates Melanoma Proliferation and Glycolytic Potential. Mol Ther Oncolytics 2020;16:30-40. [PMID: 32258386 DOI: 10.1016/j.omto.2019.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
61 Delsin LEA, Salomao KB, Pezuk JA, Brassesco MS. Expression profiles and prognostic value of miRNAs in retinoblastoma. J Cancer Res Clin Oncol 2019;145:1-10. [PMID: 30350021 DOI: 10.1007/s00432-018-2773-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
62 Soleymani J, Shafiei-Irannejad V, Hamblin MR, Hasanzadeh M, Somi MH, Jouyban A. Applications of advanced materials in bio-sensing in live cells: Methods and applications. Mater Sci Eng C Mater Biol Appl 2021;121:111691. [PMID: 33579435 DOI: 10.1016/j.msec.2020.111691] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Nie ZY, Liu XJ, Zhan Y, Liu MH, Zhang XY, Li ZY, Lu YQ, Luo JM, Yang L. miR-140-5p induces cell apoptosis and decreases Warburg effect in chronic myeloid leukemia by targeting SIX1. Biosci Rep 2019;39:BSR20190150. [PMID: 30962263 DOI: 10.1042/BSR20190150] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
64 Nicolè L, Cappello F, Cappellesso R, Vandenbussche CJ, Fassina A. MicroRNA profiling in serous cavity specimens: Diagnostic challenges and new opportunities. Cancer Cytopathology 2019;127:493-500. [DOI: 10.1002/cncy.22143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
65 Braicu OL, Budisan L, Buiga R, Jurj A, Achimas-Cadariu P, Pop LA, Braicu C, Irimie A, Berindan-Neagoe I. miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples. Onco Targets Ther 2017;10:4225-38. [PMID: 28894379 DOI: 10.2147/OTT.S137107] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
66 Ravegnini G, Sammarini G, Serrano C, Nannini M, Pantaleo MA, Hrelia P, Angelini S. Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors. Ther Adv Med Oncol 2019;11:1758835919831902. [PMID: 30854029 DOI: 10.1177/1758835919831902] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
67 Bellissimo F, Pinzone MR, Cacopardo B, Nunnari G. Diagnostic and therapeutic management of hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12003-12021 [PMID: 26576088 DOI: 10.3748/wjg.v21.i42.12003] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 41] [Article Influence: 6.1] [Reference Citation Analysis]
68 Marín-Romero A, Robles-Remacho A, Tabraue-Chávez M, López-Longarela B, Sánchez-Martín RM, Guardia-Monteagudo JJ, Fara MA, López-Delgado FJ, Pernagallo S, Díaz-Mochón JJ. A PCR-free technology to detect and quantify microRNAs directly from human plasma. Analyst 2018;143:5676-82. [PMID: 30411757 DOI: 10.1039/c8an01397g] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
69 Fattahi F, Kiani J, Khosravi M, Vafaei S, Mohammadi A, Madjd Z, Najafi M. Enrichment of Up-regulated and Down-regulated Gene Clusters Using Gene Ontology, miRNAs and lncRNAs in Colorectal Cancer. Comb Chem High Throughput Screen 2019;22:534-45. [PMID: 31654507 DOI: 10.2174/1386207321666191010114149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Wang BC, Ma J. Role of MicroRNAs in Malignant Glioma. Chin Med J (Engl) 2015;128:1238-44. [PMID: 25947409 DOI: 10.4103/0366-6999.156141] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
71 Jiang F, Yu Q, Chu Y, Zhu X, Lu W, Liu Q, Wang Q. MicroRNA-98-5p inhibits proliferation and metastasis in non-small cell lung cancer by targeting TGFBR1. Int J Oncol 2019;54:128-38. [PMID: 30387848 DOI: 10.3892/ijo.2018.4610] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
72 Wang SS, Fang YY, Huang JC, Liang YY, Guo YN, Pan LJ, Chen G. Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways. Oncol Lett 2019;18:2939-54. [PMID: 31402959 DOI: 10.3892/ol.2019.10610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
73 Fu Q, Liu CJ, Zhang X, Zhai ZS, Wang YZ, Hu MX, Xu XL, Zhang HW, Qin T. Glucocorticoid receptor regulates expression of microRNA-22 and downstream signaling pathway in apoptosis of pancreatic acinar cells. World J Gastroenterol 2018; 24(45): 5120-5130 [PMID: 30568389 DOI: 10.3748/wjg.v24.i45.5120] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
74 Hu C, Zhu S, Wang J, Lin Y, Ma L, Zhu L, Jiang P, Li Z, Pan W. Schistosoma japonicum MiRNA-7-5p Inhibits the Growth and Migration of Hepatoma Cells via Cross-Species Regulation of S-Phase Kinase-Associated Protein 2. Front Oncol 2019;9:175. [PMID: 30967999 DOI: 10.3389/fonc.2019.00175] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
75 Chen L, Huang K, Yi K, Huang Y, Tian X, Kang C. Premature MicroRNA-Based Therapeutic: A "One-Two Punch" against Cancers. Cancers (Basel) 2020;12:E3831. [PMID: 33353171 DOI: 10.3390/cancers12123831] [Reference Citation Analysis]
76 Chen Z, Zhan Y, Chi J, Guo S, Zhong X, He A, Zheng J, Gong Y, Li X, Zhou L. Using microRNAs as Novel Predictors of Urologic Cancer Survival: An Integrated Analysis. EBioMedicine 2018;34:94-107. [PMID: 30037718 DOI: 10.1016/j.ebiom.2018.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
77 Uddin MS, Mamun AA, Alghamdi BS, Tewari D, Jeandet P, Sarwar MS, Ashraf GM. Epigenetics of glioblastoma multiforme: From molecular mechanisms to therapeutic approaches. Semin Cancer Biol 2020:S1044-579X(20)30275-3. [PMID: 33370605 DOI: 10.1016/j.semcancer.2020.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
78 Liu F, Zhang H, Xie F, Tao D, Xiao X, Huang C, Wang M, Gu C, Zhang X, Jiang G. Hsa_circ_0001361 promotes bladder cancer invasion and metastasis through miR-491-5p/MMP9 axis. Oncogene 2020;39:1696-709. [PMID: 31705065 DOI: 10.1038/s41388-019-1092-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 12.0] [Reference Citation Analysis]
79 Vicentini C, Calore F, Nigita G, Fadda P, Simbolo M, Sperandio N, Luchini C, Lawlor RT, Croce CM, Corbo V, Fassan M, Scarpa A. Exosomal miRNA signatures of pancreatic lesions. BMC Gastroenterol 2020;20:137. [PMID: 32375666 DOI: 10.1186/s12876-020-01287-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
80 Henry TW, Mendoza FA, Jimenez SA. Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy. Autoimmun Rev 2019;18:102396. [PMID: 31520794 DOI: 10.1016/j.autrev.2019.102396] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
81 Waseem M, Ahmad MK, Serajuddin M, Bhaskar V, Sankhwar SN, Mahdi AA. MicroRNA-183-5p: A New Potential Marker for Prostate Cancer. Indian J Clin Biochem 2019;34:207-12. [PMID: 31092995 DOI: 10.1007/s12291-017-0731-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
82 Zhang C, Qian Y, Qiao Y, Li Y, Wang W, Li J, Deng X. Analysis of whole genome-wide microRNA transcriptome profiling in invasive pituitary adenomas and non-invasive pituitary adenomas. Chin Neurosurg J 2019;5:27. [PMID: 32922926 DOI: 10.1186/s41016-019-0177-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
83 Zhu X, Wang K, Jin Y, Wang S, Liu X, Liu H, Zhou P, Yang C, Han Z. Multiplexed fluorometric determination for three microRNAs in acute myocardial infarction by using duplex-specific nuclease and MoS2 nanosheets. Microchim Acta 2020;187. [DOI: 10.1007/s00604-019-3896-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
84 Duffy MJ, Walsh S, McDermott EW, Crown J. Biomarkers in Breast Cancer: Where Are We and Where Are We Going? Adv Clin Chem 2015;71:1-23. [PMID: 26411409 DOI: 10.1016/bs.acc.2015.05.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
85 Zou Y, Zhang Q, Zhang J, Chen X, Zhou W, Yang Z, Yang Q, Yu H, Li L, He Y, Li C, Zhang S, Zhu S, Luo B, Gao Y. A common indel polymorphism of the Desmoglein-2 (DSG2) is associated with sudden cardiac death in Chinese populations. Forensic Sci Int 2019;301:382-7. [PMID: 31220685 DOI: 10.1016/j.forsciint.2019.06.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
86 Parascandolo A, Rappa F, Cappello F, Kim J, Cantu DA, Chen H, Mazzoccoli G, Hematti P, Castellone MD, Salvatore M, Laukkanen MO. Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration. Sci Rep 2017;7:41416. [PMID: 28216675 DOI: 10.1038/srep41416] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
87 Keshavarz M, Behpour M, Rafiee-pour H. Recent trends in electrochemical microRNA biosensors for early detection of cancer. RSC Adv 2015;5:35651-60. [DOI: 10.1039/c5ra01726b] [Cited by in Crossref: 33] [Cited by in F6Publishing: 1] [Article Influence: 4.7] [Reference Citation Analysis]
88 Han Y, Zhang H, Zhou Z, Liu R, Liu D, Bai M, Fan Q, Li J, Zhu K, Li H, Ning T, Ying G, Ba Y. Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer. Int J Gen Med 2021;14:1185-95. [PMID: 33833559 DOI: 10.2147/IJGM.S297371] [Reference Citation Analysis]
89 Zhou X, Wen W, Zhu J, Huang Z, Zhang L, Zhang H, Qi LW, Shan X, Wang T, Cheng W, Zhu D, Yin Y, Chen Y, Zhu W, Shu Y, Liu P. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma. Oncotarget. 2017;8:34468-34480. [PMID: 28380431 DOI: 10.18632/oncotarget.16519] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
90 Ji Q, Xu X, Li L, Goodman SB, Bi W, Xu M, Xu Y, Fan Z, Maloney WJ, Ye Q, Wang Y. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14. Cell Death Dis 2017;8:e3103. [PMID: 29022909 DOI: 10.1038/cddis.2017.499] [Cited by in Crossref: 41] [Cited by in F6Publishing: 59] [Article Influence: 8.2] [Reference Citation Analysis]
91 Hammond SM. An overview of microRNAs. Adv Drug Deliv Rev. 2015;87:3-14. [PMID: 25979468 DOI: 10.1016/j.addr.2015.05.001] [Cited by in Crossref: 633] [Cited by in F6Publishing: 622] [Article Influence: 90.4] [Reference Citation Analysis]
92 Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Rodrigo JP, Manterola L, de Villalaín L, de Vicente JC, Alonso-Durán L, Fernández MP, Lawrie CH, García-Pedrero JM. Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts. Sci Rep 2017;7:17785. [PMID: 29259267 DOI: 10.1038/s41598-017-18138-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
93 Yu K, Rohr J, Liu Y, Li M, Xu J, Wang K, Chai J, Zhao D, Liu Y, Ma J, Fan L, Wang Z, Guo S. Progress in triple negative breast carcinoma pathophysiology: Potential therapeutic targets. Pathol Res Pract 2020;216:152874. [PMID: 32088086 DOI: 10.1016/j.prp.2020.152874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
94 Zang L, Kondengaden SM, Che F, Wang L, Heng X. Potential Epigenetic-Based Therapeutic Targets for Glioma. Front Mol Neurosci 2018;11:408. [PMID: 30498431 DOI: 10.3389/fnmol.2018.00408] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
95 Krishnan P, Ghosh S, Wang B, Heyns M, Li D, Mackey JR, Kovalchuk O, Damaraju S. Genome-wide profiling of transfer RNAs and their role as novel prognostic markers for breast cancer. Sci Rep 2016;6:32843. [PMID: 27604545 DOI: 10.1038/srep32843] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
96 Gao YF, Zhang QJ, Yu Z, Liu SH, Liang J. miR-142 suppresses proliferation and induces apoptosis of osteosarcoma cells by upregulating Rb. Oncol Lett 2018;16:733-40. [PMID: 29963139 DOI: 10.3892/ol.2018.8761] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
97 Girolami I, Lucenteforte E, Eccher A, Marletta S, Brunelli M, Graziano P, Pisapia P, Malapelle U, Troncone G, Scarpa A, Huang T, Pantanowitz L. Evidence-based diagnostic performance of novel biomarkers for the diagnosis of malignant mesothelioma in effusion cytology. Cancer Cytopathol 2021. [PMID: 34478240 DOI: 10.1002/cncy.22509] [Reference Citation Analysis]
98 Anfossi S, Babayan A, Pantel K, Calin GA. Clinical utility of circulating non-coding RNAs - an update. Nat Rev Clin Oncol 2018;15:541-63. [PMID: 29784926 DOI: 10.1038/s41571-018-0035-x] [Cited by in Crossref: 185] [Cited by in F6Publishing: 185] [Article Influence: 61.7] [Reference Citation Analysis]
99 Song PP, Xia JF, Inagaki Y, Hasegawa K, Sakamoto Y, Kokudo N, Tang W. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 262-274 [PMID: 26755875 DOI: 10.3748/wjg.v22.i1.262] [Cited by in CrossRef: 69] [Cited by in F6Publishing: 61] [Article Influence: 11.5] [Reference Citation Analysis]
100 Gulei D, Mehterov N, Ling H, Stanta G, Braicu C, Berindan-neagoe I. The “good-cop bad-cop” TGF-beta role in breast cancer modulated by non-coding RNAs. Biochimica et Biophysica Acta (BBA) - General Subjects 2017;1861:1661-75. [DOI: 10.1016/j.bbagen.2017.04.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
101 Nobili L, Lionetti M, Neri A. Long non-coding RNAs in normal and malignant hematopoiesis. Oncotarget 2016;7:50666-81. [PMID: 27177333 DOI: 10.18632/oncotarget.9308] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
102 Rong HT, Liu DW. Identification of differentially expressed miRNAs associated with thermal injury in epidermal stem cells based on RNA-sequencing. Exp Ther Med 2020;19:2218-28. [PMID: 32104287 DOI: 10.3892/etm.2020.8448] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Lou S, Ji J, Cheng X, Ruan J, Li R, Guo Z. Oncogenic miR‑132 sustains proliferation and self‑renewal potential by inhibition of polypyrimidine tract‑binding protein 2 in glioblastoma cells. Mol Med Rep 2017;16:7221-8. [PMID: 28944929 DOI: 10.3892/mmr.2017.7572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
104 Yang X, Zhao H, Yang J, Ma Y, Liu Z, Li C, Wang T, Yan Z, Du N. MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect. Biochem Biophys Res Commun 2019;515:85-91. [PMID: 31128917 DOI: 10.1016/j.bbrc.2019.05.111] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
105 Wang B, Qu XL, Liu J, Lu J, Zhou ZY. HOTAIR promotes osteosarcoma development by sponging miR-217 and targeting ZEB1. J Cell Physiol 2019;234:6173-81. [PMID: 30367466 DOI: 10.1002/jcp.27394] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
106 Liu S, Li JH, Wu J, Zhou KR, Zhou H, Yang JH, Qu LH. StarScan: a web server for scanning small RNA targets from degradome sequencing data. Nucleic Acids Res 2015;43:W480-6. [PMID: 25990732 DOI: 10.1093/nar/gkv524] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
107 Lu CX, Wu XL, Zhang GY, Gu XT, Ma X, He DX. Interplay between regulation by methylation and noncoding RNAs in cancers. Eur J Cancer Prev 2018;27:418-24. [PMID: 29557800 DOI: 10.1097/CEJ.0000000000000433] [Reference Citation Analysis]
108 Rigoutsos I, Lee SK, Nam SY, Anfossi S, Pasculli B, Pichler M, Jing Y, Rodriguez-Aguayo C, Telonis AG, Rossi S, Ivan C, Catela Ivkovic T, Fabris L, Clark PM, Ling H, Shimizu M, Redis RS, Shah MY, Zhang X, Okugawa Y, Jung EJ, Tsirigos A, Huang L, Ferdin J, Gafà R, Spizzo R, Nicoloso MS, Paranjape AN, Shariati M, Tiron A, Yeh JJ, Teruel-Montoya R, Xiao L, Melo SA, Menter D, Jiang ZQ, Flores ER, Negrini M, Goel A, Bar-Eli M, Mani SA, Liu CG, Lopez-Berestein G, Berindan-Neagoe I, Esteller M, Kopetz S, Lanza G, Calin GA. N-BLR, a primate-specific non-coding transcript leads to colorectal cancer invasion and migration. Genome Biol 2017;18:98. [PMID: 28535802 DOI: 10.1186/s13059-017-1224-0] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 13.0] [Reference Citation Analysis]
109 Li FZ, Zang WQ. Knockdown of lncRNAXLOC_001659 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells. World J Gastroenterol 2019; 25(42): 6299-6310 [PMID: 31754291 DOI: 10.3748/wjg.v25.i42.6299] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
110 Balacescu O, Visan S, Baldasici O, Balacescu L, Vlad C, Achimas-cadariu P. MiRNA-Based Therapeutics in Oncology, Realities, and Challenges. In: Sharad S, Kapur S, editors. Antisense Therapy. IntechOpen; 2019. [DOI: 10.5772/intechopen.81847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
111 Fabrizio FP, Sparaneo A, Trombetta D, Muscarella LA. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs. Oxid Med Cell Longev 2018;2018:2492063. [PMID: 29643973 DOI: 10.1155/2018/2492063] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
112 Ding C, Yu H, Shi C, Shi T, Qin H, Cui Y. MiR-let-7e inhibits invasion and magration and regulates HMGB1 expression in papillary thyroid carcinoma. Biomed Pharmacother 2019;110:528-36. [PMID: 30530288 DOI: 10.1016/j.biopha.2018.11.057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
113 Cote GJ, Grubbs EG, Hofmann MC. Thyroid C-Cell Biology and Oncogenic Transformation. Recent Results Cancer Res 2015;204:1-39. [PMID: 26494382 DOI: 10.1007/978-3-319-22542-5_1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
114 Irimie AI, Zimta AA, Ciocan C, Mehterov N, Dudea D, Braicu C, Berindan-Neagoe I. The Unforeseen Non-Coding RNAs in Head and Neck Cancer. Genes (Basel) 2018;9:E134. [PMID: 29494516 DOI: 10.3390/genes9030134] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
115 Tang RY, Wang Z, Chen HQ, Zhu SB. Negative Correlation between miR-200c and Decorin Plays an Important Role in the Pathogenesis of Colorectal Carcinoma. Biomed Res Int 2017;2017:1038984. [PMID: 28567416 DOI: 10.1155/2017/1038984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
116 Walsh CJ, Hu P, Batt J, Dos Santos CC. Discovering MicroRNA-Regulatory Modules in Multi-Dimensional Cancer Genomic Data: A Survey of Computational Methods. Cancer Inform 2016;15:25-42. [PMID: 27721651 DOI: 10.4137/CIN.S39369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
117 Nohata N, Goto Y, Gutkind JS. Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. J Hum Genet 2017;62:87-96. [PMID: 27734836 DOI: 10.1038/jhg.2016.124] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
118 Ren W, Wang D, Li C, Shu T, Zhang W, Fu X. Capn4 expression is modulated by microRNA-520b and exerts an oncogenic role in prostate cancer cells by promoting Wnt/β-catenin signaling. Biomedicine & Pharmacotherapy 2018;108:467-75. [DOI: 10.1016/j.biopha.2018.09.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
119 Xie Y, Chen L, Zhou J, Yang C, Xu C, Fan X, Tan Y, Wang Y, Kang C, Fang C. TGFβ signaling-induced miRNA participates in autophagic regulation by targeting PRAS40 in mesenchymal subtype of glioblastoma. Cancer Biol Med 2020;17:664-75. [PMID: 32944398 DOI: 10.20892/j.issn.2095-3941.2019.0356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
120 Balacescu O, Petrut B, Tudoran O, Feflea D, Balacescu L, Anghel A, Sirbu IO, Seclaman E, Marian C. Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet? WIREs RNA 2017;8:e1438. [DOI: 10.1002/wrna.1438] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
121 Liu S, Guo X, Zhong W, Weng R, Liu J, Gu X, Zhong Z. Circulating MicroRNA Expression Profiles in Patients with Stable and Unstable Angina. Clinics (Sao Paulo) 2020;75:e1546. [PMID: 32667489 DOI: 10.6061/clinics/2020/e1546] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Bhavsar SP, Løkke C, Flægstad T, Einvik C. Hsa-miR-376c-3p targets Cyclin D1 and induces G1-cell cycle arrest in neuroblastoma cells. Oncol Lett 2018;16:6786-94. [PMID: 30405823 DOI: 10.3892/ol.2018.9431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
123 Avgeris M, Tsilimantou A, Levis PK, Rampias T, Papadimitriou MA, Panoutsopoulou K, Stravodimos K, Scorilas A. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer. Carcinogenesis 2019;40:965-74. [PMID: 30815670 DOI: 10.1093/carcin/bgz045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
124 He M, Wang J, Yin Z, Zhao Y, Hou H, Fan J, Li H, Wen Z, Tang J, Wang Y, Wang DW, Chen C. MiR-320a induces diabetic nephropathy via inhibiting MafB. Aging (Albany NY) 2019;11:3055-79. [PMID: 31102503 DOI: 10.18632/aging.101962] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 10.5] [Reference Citation Analysis]
125 Wang S, Zhang Z, Yang Y, Wang C, Tao R, Hu S, Yin Z, Zhang Q, Li L, He Y, Zhu S, Li C, Zhang S, Zhang J, Sheng L, Wu F, Luo B, Gao Y. An insertion/deletion polymorphism within 3'UTR of RYR2 modulates sudden unexplained death risk in Chinese populations. Forensic Sci Int 2017;270:165-72. [PMID: 27987400 DOI: 10.1016/j.forsciint.2016.12.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
126 Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes-Mattei E, Xiao L, Vannini I, Redis RS, D'Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo PP, Ruvolo VR, Pecot CV, Amadori D, Abruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski R, Plunkett W, Lichtenberg TM, Davuluri RV, Berindan-Neagoe I, Negrini M, Wistuba II, Kantarjian HM, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GA. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clin Cancer Res 2017;23:2891-904. [PMID: 27903673 DOI: 10.1158/1078-0432.CCR-16-1025] [Cited by in Crossref: 67] [Cited by in F6Publishing: 50] [Article Influence: 11.2] [Reference Citation Analysis]
127 Robb T, Reid G, Blenkiron C. Exploiting microRNAs As Cancer Therapeutics. Targ Oncol 2017;12:163-78. [DOI: 10.1007/s11523-017-0476-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
128 Wang Y, Ji J, Weng H, Wang B, Wang F. MiR-139 in digestive system tumor diagnosis and detection: Bioinformatics and meta-analysis. Clinica Chimica Acta 2018;485:33-41. [DOI: 10.1016/j.cca.2018.06.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
129 Yin H, Wang X, Zhang X, Wang Y, Zeng Y, Xiong Y, Li T, Lin R, Zhou Q, Ling H, Zhou F, Zhou Y. Integrated analysis of long noncoding RNA associated-competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma. Cancer Sci 2018;109:3336-49. [PMID: 30152187 DOI: 10.1111/cas.13778] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 5.3] [Reference Citation Analysis]
130 Jiang M, Shi L, Yang C, Ge Y, Lin L, Fan H, He Y, Zhang D, Miao Y, Yang L. miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer. Cell Death Dis 2019;10:32. [PMID: 30631050 DOI: 10.1038/s41419-018-1262-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 11.7] [Reference Citation Analysis]
131 Forterre A, Komuro H, Aminova S, Harada M. A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies. Cancers (Basel) 2020;12:E1852. [PMID: 32660045 DOI: 10.3390/cancers12071852] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
132 Deng X, Yin Z, Lu J, Xia Y, Shao L, Hu Q, Zhou Z, Zhang F, Zhou S, Wu Y, Sheng W, Zeng Y. Two-Step Assembling of Near-Infrared “OFF–ON” Fluorescent Nanohybrids for Synchronous Tumor Imaging and MicroRNA Modulation-Based Therapy. ACS Appl Mater Interfaces 2017;9:3294-305. [DOI: 10.1021/acsami.6b11438] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
133 Bica-Pop C, Cojocneanu-Petric R, Magdo L, Raduly L, Gulei D, Berindan-Neagoe I. Overview upon miR-21 in lung cancer: focus on NSCLC. Cell Mol Life Sci 2018;75:3539-51. [PMID: 30030592 DOI: 10.1007/s00018-018-2877-x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 82] [Article Influence: 20.0] [Reference Citation Analysis]
134 Ronchetti D, Agnelli L, Taiana E, Galletti S, Manzoni M, Todoerti K, Musto P, Strozzi F, Neri A. Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma. Oncotarget 2016;7:14814-30. [PMID: 26895470 DOI: 10.18632/oncotarget.7442] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
135 Rohan T, Ye K, Wang Y, Glass AG, Ginsberg M, Loudig O. MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 2018;13:e0191814. [PMID: 29432432 DOI: 10.1371/journal.pone.0191814] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
136 Cavalcanti E, Galleggiante V, Coletta S, Stasi E, Chieppa M, Armentano R, Serino G. Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades. Front Oncol 2020;10:1187. [PMID: 32766159 DOI: 10.3389/fonc.2020.01187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
137 Xie P, Li X, Tan X, Sun X, Wang C, Yu J. Sequential Serum Let-7 Is a Novel Biomarker to Predict Accelerated Reproliferation During Fractional Radiotherapy in Lung Cancer. Clinical Lung Cancer 2016;17:e95-e101. [DOI: 10.1016/j.cllc.2016.03.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
138 Sun W, Yi Y, Xia G, Zhao Y, Yu Y, Li L, Hua C, He B, Yang B, Yu C, Ye C, Tu F, Chen C, Xu X, Zheng Z, Wang W, Shen X. Nrf2-miR-129-3p-mTOR Axis Controls an miRNA Regulatory Network Involved in HDACi-Induced Autophagy. Mol Ther 2019;27:1039-50. [PMID: 30852137 DOI: 10.1016/j.ymthe.2019.02.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
139 Kim DH, Khan H, Ullah H, Hassan STS, Šmejkal K, Efferth T, Mahomoodally MF, Xu S, Habtemariam S, Filosa R, Lagoa R, Rengasamy KR. MicroRNA targeting by quercetin in cancer treatment and chemoprotection. Pharmacol Res 2019;147:104346. [PMID: 31295570 DOI: 10.1016/j.phrs.2019.104346] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
140 Monroig-Bosque Pdel C, Rivera CA, Calin GA. MicroRNAs in cancer therapeutics: "from the bench to the bedside". Expert Opin Biol Ther 2015;15:1381-5. [PMID: 26372796 DOI: 10.1517/14712598.2015.1074999] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
141 Ma Q, Shu C, Wang J. Bioinformatics analysis of microarray data reveals epithelial-mesenchymal-transition in pediatric ependymoma. Anticancer Drugs 2021;32:437-47. [PMID: 33595943 DOI: 10.1097/CAD.0000000000001046] [Reference Citation Analysis]
142 Zhang Z, Xing T, Chen Y, Xiao J. Exosome-mediated miR-200b promotes colorectal cancer proliferation upon TGF-β1 exposure. Biomed Pharmacother 2018;106:1135-43. [PMID: 30119180 DOI: 10.1016/j.biopha.2018.07.042] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 5.3] [Reference Citation Analysis]
143 Raad M, Salehi Z, Habibzaadeh Baalsini M, Mashayekhi F, Saeidi Saedi H. Association of rs2620381 polymorphism in miR-627 and gastric cancer. British Journal of Biomedical Science 2020;77:76-80. [DOI: 10.1080/09674845.2019.1692762] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
144 Xu L, Zheng Q. Identification and validation of a miRNA-related expression signature for tumor mutational burden in colorectal cancer. World J Surg Oncol 2021;19:56. [PMID: 33610190 DOI: 10.1186/s12957-021-02137-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
145 Dang S, Zhou J, Chen Y, Chen P, Ji M, Shi B, Yang Q, Hou P. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis. Oncogene 2019;38:4804-19. [PMID: 30804458 DOI: 10.1038/s41388-019-0759-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
146 Pan W, Yu S, Jia J, Hu J, Jie L, Zhang P, Wang Q, Yan X, Qiu Y. Deregulation of the cell cycle and related microRNA expression induced by vinyl chloride monomer in the hepatocytes of rats. Toxicol Ind Health 2021;37:365-76. [PMID: 33973497 DOI: 10.1177/07482337211015591] [Reference Citation Analysis]
147 Guo Z, Jia H, Ge J. MiR-206 suppresses proliferation and epithelial-mesenchymal transition of renal cell carcinoma by inhibiting CDK6 expression. Hum Cell 2020;33:750-8. [PMID: 32277426 DOI: 10.1007/s13577-020-00355-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
148 Panwar B, Omenn GS, Guan Y. miRmine: a database of human miRNA expression profiles. Bioinformatics 2017;33:1554-60. [PMID: 28108447 DOI: 10.1093/bioinformatics/btx019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 72] [Article Influence: 9.3] [Reference Citation Analysis]
149 Ren A, Wen Z, Zheng L. Downregulation of miR-3934-5p enhances A549 cell sensitivity to cisplatin by targeting TP53INP1. Exp Ther Med 2019;18:1653-60. [PMID: 31410122 DOI: 10.3892/etm.2019.7718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
150 Gulei D, Petrut B, Tigu AB, Onaciu A, Fischer-Fodor E, Atanasov AG, Ionescu C, Berindan-Neagoe I. Exosomes at a glance - common nominators for cancer hallmarks and novel diagnosis tools. Crit Rev Biochem Mol Biol 2018;53:564-77. [PMID: 30247075 DOI: 10.1080/10409238.2018.1508276] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
151 Roychowdhury S, Chinnaiyan AM. Translating cancer genomes and transcriptomes for precision oncology. CA Cancer J Clin. 2016;66:75-88. [PMID: 26528881 DOI: 10.3322/caac.21329] [Cited by in Crossref: 98] [Cited by in F6Publishing: 91] [Article Influence: 14.0] [Reference Citation Analysis]
152 Reda El Sayed S, Cristante J, Guyon L, Denis J, Chabre O, Cherradi N. MicroRNA Therapeutics in Cancer: Current Advances and Challenges. Cancers (Basel) 2021;13:2680. [PMID: 34072348 DOI: 10.3390/cancers13112680] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
153 Xiao Y, Deng T, Su C, Shang Z. MicroRNA 217 inhibits cell proliferation and enhances chemosensitivity to doxorubicin in acute myeloid leukemia by targeting KRAS. Oncol Lett 2017;13:4986-94. [PMID: 28599501 DOI: 10.3892/ol.2017.6076] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
154 Haranguș A, Berindan-Neagoe I, Todea DA, Șimon I, Șimon M. Noncoding RNAs and Liquid Biopsy in Lung Cancer: A Literature Review. Diagnostics (Basel) 2019;9:E216. [PMID: 31818027 DOI: 10.3390/diagnostics9040216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
155 Wang Z, Gao L, Guo X, Feng C, Deng K, Lian W, Xing B. Identification of microRNAs associated with the aggressiveness of prolactin pituitary tumors using bioinformatic analysis. Oncol Rep 2019;42:533-48. [PMID: 31173251 DOI: 10.3892/or.2019.7173] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
156 Huang Y, Chen Z, Zhou X, Huang H. Circ_0000467 Exerts an Oncogenic Role in Colorectal Cancer via miR-330-5p-Dependent Regulation of TYRO3. Biochem Genet 2022. [PMID: 35039980 DOI: 10.1007/s10528-021-10171-7] [Reference Citation Analysis]
157 Li W, Zhang Z, Wang B, Liang N, Zhou Q, Long S. MicroRNA and cyclooxygenase-2 in breast cancer. Clin Chim Acta 2021;522:36-44. [PMID: 34389281 DOI: 10.1016/j.cca.2021.08.007] [Reference Citation Analysis]
158 Aita A, Millino C, Sperti C, Pacchioni B, Plebani M, Pittà C, Basso D. Serum miRNA Profiling for Early PDAC Diagnosis and Prognosis: A Retrospective Study. Biomedicines 2021;9:845. [PMID: 34356909 DOI: 10.3390/biomedicines9070845] [Reference Citation Analysis]
159 Busch M, Miroschnikov N, Dankert JT, Wiesehöfer M, Metz K, Stephan H, Dünker N. Impact of RARα and miR-138 on retinoblastoma etoposide resistance. Tumour Biol 2021;43:11-26. [PMID: 33935126 DOI: 10.3233/TUB-200072] [Reference Citation Analysis]
160 Dong X, Chang M, Song X, Ding S, Xie L, Song X. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer. Thorac Cancer 2021;12:539-48. [PMID: 33372399 DOI: 10.1111/1759-7714.13800] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
161 Sun X, Xu W, Zang C, Li N. miRNA-520c-3p accelerates progression of nasopharyngeal carcinoma via targeting RAB22A. Oncol Lett 2020;19:771-6. [PMID: 31897193 DOI: 10.3892/ol.2019.11144] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
162 Zhu QN, Renaud H, Guo Y. Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy. Hereditas 2018;155:17. [PMID: 29371858 DOI: 10.1186/s41065-018-0055-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
163 Huang J, He Y, Mcleod HL, Xie Y, Xiao D, Hu H, Chen P, Shen L, Zeng S, Yin X, Ge J, Li L, Tang L, Ma J, Chen Z. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer. BMC Cancer 2017;17:886. [PMID: 29273006 DOI: 10.1186/s12885-017-3875-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
164 Zeng MS. Noncoding RNAs in Cancer Diagnosis. Adv Exp Med Biol 2016;927:391-427. [PMID: 27376744 DOI: 10.1007/978-981-10-1498-7_15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
165 Bojan A, Berindan-Neagoe I, Ciurea S, Dima D, Fuji S, Ghiaur G, Grewal R, Mccormack E, Tanase A, Trifa A, Tomuleasa C. Proceedings from the 1st Insights in Hematology Symposium, Cluj-Napoca, Romania March 11-12, 2016. Rom J Intern Med 2016;54:157-60. [PMID: 27658163 DOI: 10.1515/rjim-2016-0028] [Reference Citation Analysis]
166 de Almeida BC, Garcia N, Maffazioli G, dos Anjos LG, Baracat EC, Carvalho KC. Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells. Int J Mol Sci 2017;19:E52. [PMID: 29295562 DOI: 10.3390/ijms19010052] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
167 Milunović V, Mandac Rogulj I, Planinc-Peraica A, Bulycheva E, Kolonić Ostojić S. The role of microRNA in myelodysplastic syndromes: beyond DNA methylation and histone modification. Eur J Haematol 2016;96:553-63. [PMID: 26773284 DOI: 10.1111/ejh.12735] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
168 Alshehri B. Plant-derived xenomiRs and cancer: Cross-kingdom gene regulation. Saudi J Biol Sci 2021;28:2408-22. [PMID: 33911956 DOI: 10.1016/j.sjbs.2021.01.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Gulei D, Raduly L, Broseghini E, Ferracin M, Berindan-Neagoe I. The extensive role of miR-155 in malignant and non-malignant diseases. Mol Aspects Med 2019;70:33-56. [PMID: 31558293 DOI: 10.1016/j.mam.2019.09.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
170 Lin J, Ding S, Xie C, Yi R, Wu Z, Luo J, Huang T, Zeng Y, Wang X, Xu A, Xiao J, Song Y, Zhang X. MicroRNA-4476 promotes glioma progression through a miR-4476/APC/β-catenin/c-Jun positive feedback loop. Cell Death Dis 2020;11:269. [PMID: 32327666 DOI: 10.1038/s41419-020-2474-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
171 Cao H, Pan G, Tang S, Zhong N, Liu H, Zhou H, Peng Q, Zou Y. miR-145-5p Regulates the Proliferation, Migration and Invasion in Cervical Carcinoma by Targeting KLF5. Onco Targets Ther 2020;13:2369-76. [PMID: 32256087 DOI: 10.2147/OTT.S241366] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
172 Jian C, Lu M, Zhang Z, Liu L, Li X, Huang F, Xu N, Qin L, Zhang Q, Zou D. miR-34a knockout attenuates cognitive deficits in APP/PS1 mice through inhibition of the amyloidogenic processing of APP. Life Sci 2017;182:104-11. [PMID: 28533191 DOI: 10.1016/j.lfs.2017.05.023] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
173 Gulei D, Berindan-Neagoe I. Combined Therapy in Cancer: The Non-coding Approach. Mol Ther Nucleic Acids 2018;12:787-92. [PMID: 30141411 DOI: 10.1016/j.omtn.2018.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
174 Lin K, Huang J, Luo H, Luo C, Zhu X, Bu F, Xiao H, Xiao L, Zhu Z. Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer. Aging (Albany NY) 2020;12:5832-57. [PMID: 32235004 DOI: 10.18632/aging.102979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
175 Javidi MA, Ahmadi AH, Bakhshinejad B, Nouraee N, Babashah S, Sadeghizadeh M. Cell-free microRNAs as cancer biomarkers: the odyssey of miRNAs through body fluids. Med Oncol. 2014;31:295. [PMID: 25362261 DOI: 10.1007/s12032-014-0295-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
176 Feng C, Yuan X, Chu K, Zhang H, Ji W, Rui M. Preparation and optimization of poly (lactic acid) nanoparticles loaded with fisetin to improve anti-cancer therapy. Int J Biol Macromol 2019;125:700-10. [PMID: 30521927 DOI: 10.1016/j.ijbiomac.2018.12.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
177 Gulei D, Magdo L, Jurj A, Raduly L, Cojocneanu-Petric R, Moldovan A, Moldovan C, Florea A, Pasca S, Pop LA, Moisoiu V, Budisan L, Pop-Bica C, Ciocan C, Buiga R, Muresan MS, Stiufiuc R, Ionescu C, Berindan-Neagoe I. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression. Cell Death Dis 2018;9:66. [PMID: 29352232 DOI: 10.1038/s41419-017-0102-8] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 10.5] [Reference Citation Analysis]
178 Li ZZ, Shen LF, Li YY, Chen P, Chen LZ. Clinical utility of microRNA-378 as early diagnostic biomarker of human cancers: a meta-analysis of diagnostic test. Oncotarget 2016;7:58569-78. [PMID: 27448977 DOI: 10.18632/oncotarget.10707] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
179 Xing W, Zeng C. A novel serum microRNA-based identification and classification biomarker of human glioma. Tumour Biol 2017;39:1010428317705339. [PMID: 28475008 DOI: 10.1177/1010428317705339] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
180 Hong X, Zhang Z, Pan L, Ma W, Zhai X, Gu C, Zhang Y, Bi X, Huang W, Pei H, Liu Z. MicroRNA-301b promotes the proliferation and invasion of glioma cells through enhancing activation of Wnt/β-catenin signaling via targeting Glypican-5. Eur J Pharmacol 2019;854:39-47. [PMID: 30951720 DOI: 10.1016/j.ejphar.2019.03.057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
181 Liang J, Liu Y, Zhang L, Tan J, Li E, Li F. Overexpression of microRNA-519d-3p suppressed the growth of pancreatic cancer cells by inhibiting ribosomal protein S15A-mediated Wnt/β-catenin signaling. Chem Biol Interact 2019;304:1-9. [PMID: 30831090 DOI: 10.1016/j.cbi.2019.02.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
182 Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis. Gene. 2018;673:181-193. [PMID: 29913239 DOI: 10.1016/j.gene.2018.06.037] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 11.3] [Reference Citation Analysis]
183 Song P, Tang Q, Feng X, Tang W. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma. Scand J Clin Lab Invest Suppl 2016;245:S70-6. [PMID: 27438343 DOI: 10.1080/00365513.2016.1210328] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
184 Hsieh FM, Lai ST, Wu MF, Lin CC. Identification and Elucidation of the Protective isomiRs in Lung Cancer Patient Prognosis. Front Genet 2021;12:702695. [PMID: 34589114 DOI: 10.3389/fgene.2021.702695] [Reference Citation Analysis]
185 Okugawa Y, Toiyama Y, Toden S, Mitoma H, Nagasaka T, Tanaka K, Inoue Y, Kusunoki M, Boland CR, Goel A. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer. Gut 2017;66:107-17. [PMID: 26475630 DOI: 10.1136/gutjnl-2015-309359] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 9.3] [Reference Citation Analysis]
186 Ciccone M, Calin GA. MicroRNAs in Myeloid Hematological Malignancies. Curr Genomics 2015;16:336-48. [PMID: 27047254 DOI: 10.2174/138920291605150710122815] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
187 Sun S, Wang Y, Zhou R, Deng Z, Han Y, Han X, Tao W, Yang Z, Shi C, Hong D, Li J, Shi D, Zhang Z. Targeting and Regulating of an Oncogene via Nanovector Delivery of MicroRNA using Patient-Derived Xenografts. Theranostics 2017;7:677-93. [PMID: 28255359 DOI: 10.7150/thno.16357] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
188 Liang C, Sun W, He H, Zhang B, Ling C, Wang B, Huang T, Hou B, Guo Y. Antitumor effect of a new nano-vector with miRNA-135a on malignant glioma. Int J Nanomedicine 2018;13:209-20. [PMID: 29343959 DOI: 10.2147/IJN.S148142] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
189 Sheng Z, Lu W, Zuo Z, Wang D, Zuo P, Yao Y, Ma G. MicroRNA-7b attenuates ischemia/reperfusion-induced H9C2 cardiomyocyte apoptosis via the hypoxia inducible factor-1/p-p38 pathway. J Cell Biochem 2019;120:9947-55. [PMID: 30548297 DOI: 10.1002/jcb.28277] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
190 Wang L, Sun J, Cao H. MicroRNA-384 regulates cell proliferation and apoptosis through directly targeting WISP1 in laryngeal cancer. J Cell Biochem 2019;120:3018-26. [PMID: 30548664 DOI: 10.1002/jcb.27323] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
191 Perrier A, Didelot A, Laurent-Puig P, Blons H, Garinet S. Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors. Biomolecules 2020;10:E1061. [PMID: 32708698 DOI: 10.3390/biom10071061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
192 Liao CH, Liu Y, Wu YF, Zhu SW, Cai RY, Zhou L, Yin XM. microRNA-329 suppresses epithelial-to-mesenchymal transition and lymph node metastasis in bile duct cancer by inhibiting laminin subunit beta 3. J Cell Physiol 2019;234:17786-99. [PMID: 30887508 DOI: 10.1002/jcp.28404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
193 Alves R, Gonçalves AC, Jorge J, Marques G, Luís D, Ribeiro AB, Freitas-Tavares P, Oliveiros B, Almeida AM, Sarmento-Ribeiro AB. MicroRNA signature refine response prediction in CML. Sci Rep 2019;9:9666. [PMID: 31273251 DOI: 10.1038/s41598-019-46132-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
194 Balacescu O, Dumitrescu RG, Marian C. MicroRNAs Role in Prostate Cancer. In: Dumitrescu RG, Verma M, editors. Cancer Epigenetics for Precision Medicine. New York: Springer; 2018. pp. 103-17. [DOI: 10.1007/978-1-4939-8751-1_6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
195 Liu X, Zhong L, Jiang W, Wen D. Repression of circRNA_000684 inhibits malignant phenotypes of pancreatic ductal adenocarcinoma cells via miR-145-mediated KLF5. Pancreatology 2021;21:406-17. [PMID: 33563550 DOI: 10.1016/j.pan.2020.12.023] [Reference Citation Analysis]
196 Di Benedetto P, Ruscitti P, Berardicurti O, Vomero M, Navarini L, Dolo V, Cipriani P, Giacomelli R. Endothelial-to-mesenchymal transition in systemic sclerosis. Clin Exp Immunol 2021;205:12-27. [PMID: 33772754 DOI: 10.1111/cei.13599] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Liu L, Wang Y, Bai R, Yang K, Tian Z. MiR-186 inhibited aerobic glycolysis in gastric cancer via HIF-1α regulation. Oncogenesis 2016;5:e224. [PMID: 27159677 DOI: 10.1038/oncsis.2016.35] [Cited by in Crossref: 44] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
198 Li X, Seebacher NA, Hornicek FJ, Xiao T, Duan Z. Application of liquid biopsy in bone and soft tissue sarcomas: Present and future. Cancer Lett. 2018;439:66-77. [PMID: 30223067 DOI: 10.1016/j.canlet.2018.09.012] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
199 Li LJ, Chang WM, Hsiao M. Aberrant Expression of microRNA Clusters in Head and Neck Cancer Development and Progression: Current and Future Translational Impacts. Pharmaceuticals (Basel) 2021;14:194. [PMID: 33673471 DOI: 10.3390/ph14030194] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
200 Quinn L, Finn SP, Cuffe S, Gray SG. Non-coding RNA repertoires in malignant pleural mesothelioma. Lung Cancer 2015;90:417-26. [PMID: 26791801 DOI: 10.1016/j.lungcan.2015.11.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
201 Liu Y, Ye F. Construction and integrated analysis of crosstalking ceRNAs networks in laryngeal squamous cell carcinoma. PeerJ 2019;7:e7380. [PMID: 31367490 DOI: 10.7717/peerj.7380] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
202 Gonzalez Dos Anjos L, de Almeida BC, Gomes de Almeida T, Mourão Lavorato Rocha A, De Nardo Maffazioli G, Soares FA, Werneck da Cunha I, Baracat EC, Carvalho KC. Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment? Cancers (Basel) 2018;10:E315. [PMID: 30200635 DOI: 10.3390/cancers10090315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
203 Solé C, Lawrie CH. MicroRNAs in Metastasis and the Tumour Microenvironment. Int J Mol Sci 2021;22:4859. [PMID: 34064331 DOI: 10.3390/ijms22094859] [Reference Citation Analysis]
204 Dudics S, Venkatesha SH, Moudgil KD. The Micro-RNA Expression Profiles of Autoimmune Arthritis Reveal Novel Biomarkers of the Disease and Therapeutic Response. Int J Mol Sci 2018;19:E2293. [PMID: 30081592 DOI: 10.3390/ijms19082293] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
205 Balacescu O, Balacescu L, Baldasici O, Tudoran O, Achimas‐cadariu P. The Role of miRNAs in Diagnosis, Prognosis and Treatment Prediction in Cervical Cancer. In: Rajkumar R, editor. Colposcopy and Cervical Pathology. InTech; 2017. [DOI: 10.5772/68011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
206 Chen Q, Luo G, Zhang X. MiR-148a modulates HLA-G expression and influences tumor apoptosis in esophageal squamous cell carcinoma. Exp Ther Med 2017;14:4448-52. [PMID: 29067119 DOI: 10.3892/etm.2017.5058] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
207 Mazurek M, Grochowski C, Litak J, Osuchowska I, Maciejewski R, Kamieniak P. Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme. Int J Mol Sci 2020;21:E3046. [PMID: 32349263 DOI: 10.3390/ijms21093046] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
208 Krajewska JB, Fichna J, Mosińska P. One step ahead: miRNA-34 in colon cancer-future diagnostic and therapeutic tool? Crit Rev Oncol Hematol 2018;132:1-8. [PMID: 30447913 DOI: 10.1016/j.critrevonc.2018.09.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
209 Liu H, Su P, Zhi L, Zhao K. miR‑34c‑3p acts as a tumor suppressor gene in osteosarcoma by targeting MARCKS. Mol Med Rep 2017;15:1204-10. [PMID: 28075441 DOI: 10.3892/mmr.2017.6108] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
210 Wang T, Fu X, Jin T, Zhang L, Liu B, Wu Y, Xu F, Wang X, Ye K, Zhang W, Ye L. Aspirin targets P4HA2 through inhibiting NF-κB and LMCD1-AS1/let-7g to inhibit tumour growth and collagen deposition in hepatocellular carcinoma. EBioMedicine 2019;45:168-80. [PMID: 31278071 DOI: 10.1016/j.ebiom.2019.06.048] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 9.7] [Reference Citation Analysis]
211 Ali HEA, Abdel Hameed R, Effat H, Ahmed EK, Atef AA, Sharawi SK, Ali M, Abd Elmageed ZY, Abdel Wahab AH. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2017;41:e51-e62. [PMID: 28750770 DOI: 10.1016/j.clinre.2017.06.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
212 Schwarzenbach H, Gahan PB. MicroRNA Shuttle from Cell-To-Cell by Exosomes and Its Impact in Cancer. Noncoding RNA 2019;5:E28. [PMID: 30901915 DOI: 10.3390/ncrna5010028] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
213 Fattahi F, Kiani J, Alemrajabi M, Soroush A, Naseri M, Najafi M, Madjd Z. Overexpression of DDIT4 and TPTEP1 are associated with metastasis and advanced stages in colorectal cancer patients: a study utilizing bioinformatics prediction and experimental validation. Cancer Cell Int 2021;21:303. [PMID: 34107956 DOI: 10.1186/s12935-021-02002-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Finotti A, Fabbri E, Lampronti I, Gasparello J, Borgatti M, Gambari R. MicroRNAs and Long Non-coding RNAs in Genetic Diseases. Mol Diagn Ther 2019;23:155-71. [PMID: 30610665 DOI: 10.1007/s40291-018-0380-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
215 Guo Y, Sun W, Gong T, Chai Y, Wang J, Hui B, Li Y, Song L, Gao Y. miR-30a radiosensitizes non-small cell lung cancer by targeting ATF1 that is involved in the phosphorylation of ATM. Oncol Rep 2017;37:1980-8. [PMID: 28259977 DOI: 10.3892/or.2017.5448] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
216 Gao Y, Li X, Zhi H, Zhang Y, Wang P, Wang Y, Shang S, Fang Y, Shen W, Ning S, Chen SX, Li X. Comprehensive Characterization of Somatic Mutations Impacting lncRNA Expression for Pan-Cancer. Mol Ther Nucleic Acids 2019;18:66-79. [PMID: 31525663 DOI: 10.1016/j.omtn.2019.08.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
217 Cohen A, Burgos-Aceves MA, Smith Y. Estrogen repression of microRNA as a potential cause of cancer. Biomed Pharmacother. 2016;78:234-238. [PMID: 26898447 DOI: 10.1016/j.biopha.2016.01.023] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
218 Sarkar N, Kumar A. microRNAs: New-Age Panacea in Cancer Therapeutics. Indian J Surg Oncol 2021;12:52-6. [PMID: 33994728 DOI: 10.1007/s13193-020-01110-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
219 Zhao L, Wang J, Shi S, Wu Y, Liu J, He S, Zou Y, Xie H, Ge S, Ye H. Plasma miRNA profiles associated with stable warfarin dosage in Chinese patients. PeerJ 2020;8:e9995. [PMID: 33083118 DOI: 10.7717/peerj.9995] [Reference Citation Analysis]
220 Chen W, Fan XM, Mao L, Zhang JY, Li J, Wu JZ, Tang JH. MicroRNA-224: as a potential target for miR-based therapy of cancer. Tumour Biol 2015;36:6645-52. [PMID: 26254100 DOI: 10.1007/s13277-015-3883-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
221 Bayraktar R, Van Roosbroeck K, Calin GA. Cell-to-cell communication: microRNAs as hormones. Mol Oncol. 2017;11:1673-1686. [PMID: 29024380 DOI: 10.1002/1878-0261.12144] [Cited by in Crossref: 149] [Cited by in F6Publishing: 147] [Article Influence: 29.8] [Reference Citation Analysis]
222 Wu Z, Liu K, Wang Y, Xu Z, Meng J, Gu S. Upregulation of microRNA-96 and its oncogenic functions by targeting CDKN1A in bladder cancer. Cancer Cell Int 2015;15:107. [PMID: 26582573 DOI: 10.1186/s12935-015-0235-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
223 He J, Jiang Y, Liu L, Zuo Z, Zeng C. Circulating MicroRNAs as Promising Diagnostic Biomarkers for Patients With Glioma: A Meta-Analysis. Front Neurol 2020;11:610163. [PMID: 33597912 DOI: 10.3389/fneur.2020.610163] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
224 Weissman R, Diamond EL, Haroche J, Pillar N, Shapira G, Durham BH, Buthorn J, Cohen F, Ki M, Stemer G, Ulaner GA, Amoura Z, Emile JF, Mazor RD, Shomron N, Abdel-Wahab OI, Shpilberg O, Hershkovitz-Rokah O. The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim-Chester Disease. Cancers (Basel) 2020;12:E3240. [PMID: 33153128 DOI: 10.3390/cancers12113240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
225 Longqiu Y, Pengcheng L, Xuejie F, Peng Z. A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1. Cancer Med 2016;5:2022-31. [PMID: 27230463 DOI: 10.1002/cam4.760] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
226 Zhou X, Dou M, Liu Z, Jiao D, Li Z, Chen J, Li J, Yao Y, Li L, Li Y, Han X. Screening Prognosis-Related lncRNAs Based on WGCNA to Establish a New Risk Score for Predicting Prognosis in Patients with Hepatocellular Carcinoma. J Immunol Res 2021;2021:5518908. [PMID: 34426790 DOI: 10.1155/2021/5518908] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
227 Tang D, Yang Z, Long F, Luo L, Yang B, Zhu R, Sang X, Cao G, Wang K. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis. J Cell Physiol 2019;234:20816-28. [PMID: 31012108 DOI: 10.1002/jcp.28687] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
228 Chen X, Shi K, Wang Y, Song M, Zhou W, Tu H, Lin Z. Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation. Oncotarget 2015;6:37544-56. [PMID: 26462034 DOI: 10.18632/oncotarget.6065] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
229 Chen J, Du G, Wang Y, Shi L, Mi J, Tang G. Integrative analysis of mRNA and miRNA expression profiles in oral lichen planus: preliminary results. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 2017;124:390-402.e17. [DOI: 10.1016/j.oooo.2017.05.513] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
230 Lyu J, Zhao L, Wang F, Ji J, Cao Z, Xu H, Shi X, Zhu Y, Zhang C, Guo F, Yang B, Sun Y. Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population. Biomed Res Int 2019;2019:9306803. [PMID: 31534967 DOI: 10.1155/2019/9306803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
231 Haranguş A, Berindan-Neagoe I, Toma L, Şimon I, Pop O, Şimon M. EBUS in optimizing non-small cell lung cancer diagnosis and treatment. Med Pharm Rep 2021;94:176-84. [PMID: 34013188 DOI: 10.15386/mpr-1725] [Reference Citation Analysis]
232 Koufaris C. Human and primate-specific microRNAs in cancer: Evolution, and significance in comparison with more distantly-related research models: The great potential of evolutionary young microRNA in cancer research. BioEssays 2016;38:286-94. [DOI: 10.1002/bies.201500135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
233 Kersy O, Salmon-Divon M, Shpilberg O, Hershkovitz-Rokah O. Non-Coding RNAs in Normal B-Cell Development and in Mantle Cell Lymphoma: From Molecular Mechanism to Biomarker and Therapeutic Agent Potential. Int J Mol Sci 2021;22:9490. [PMID: 34502399 DOI: 10.3390/ijms22179490] [Reference Citation Analysis]
234 Long M, Zhan M, Xu S, Yang R, Chen W, Zhang S, Shi Y, He Q, Mohan M, Liu Q, Wang J. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Mol Cancer 2017;16:167. [PMID: 29078789 DOI: 10.1186/s12943-017-0723-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 59] [Article Influence: 10.6] [Reference Citation Analysis]
235 Wang W, Su Y, Tang S, Li H, Xie W, Chen J, Shen L, Pan X, Ning B. Identification of noncoding RNA expression profiles and regulatory interaction networks following traumatic spinal cord injury by sequence analysis. Aging (Albany NY) 2019;11:2352-68. [PMID: 30998503 DOI: 10.18632/aging.101919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
236 Filipów S, Łaczmański Ł. Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response. Front Genet 2019;10:169. [PMID: 30915102 DOI: 10.3389/fgene.2019.00169] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
237 Zhang S, Chen H, Liu W, Fang L, Qian Z, Kong R, Zhang Q, Li J, Cao X. miR-766-3p Targeting BCL9L Suppressed Tumorigenesis, Epithelial-Mesenchymal Transition, and Metastasis Through the β-Catenin Signaling Pathway in Osteosarcoma Cells. Front Cell Dev Biol 2020;8:594135. [PMID: 33117820 DOI: 10.3389/fcell.2020.594135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
238 Kumar AS, Rayala SK, Venkatraman G. Targeting IGF1R pathway in cancer with microRNAs: How close are we? RNA Biol 2018;15:320-6. [PMID: 28613101 DOI: 10.1080/15476286.2017.1338240] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
239 Yu Y, Zhang J, Jin Y, Yang Y, Shi J, Chen F, Han S, Chu P, Lu J, Wang H, Guo Y, Ni X. MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma. Cancer Cell Int 2018;18:5. [PMID: 29311760 DOI: 10.1186/s12935-017-0499-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
240 Schütte K, Schulz C, Link A, Malfertheiner P. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis. World J Hepatol 2015; 7(2): 139-149 [PMID: 25729470 DOI: 10.4254/wjh.v7.i2.139] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
241 Grobbelaar C, Ford AM. The Role of MicroRNA in Paediatric Acute Lymphoblastic Leukaemia: Challenges for Diagnosis and Therapy. J Oncol. 2019;2019:8941471. [PMID: 31737072 DOI: 10.1155/2019/8941471] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
242 Shan X, Zhang H, Zhang L, Zhou X, Wang T, Zhang J, Shu Y, Zhu W, Wen W, Liu P. Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China. Cancer Med 2018;7:2370-81. [PMID: 29673101 DOI: 10.1002/cam4.1490] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
243 Liang T, Li L, Cheng Y, Ren C, Zhang G. MicroRNA-194 promotes the growth, migration, and invasion of ovarian carcinoma cells by targeting protein tyrosine phosphatase nonreceptor type 12. Onco Targets Ther 2016;9:4307-15. [PMID: 27486333 DOI: 10.2147/OTT.S90976] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
244 Irimie AI, Ciocan C, Gulei D, Mehterov N, Atanasov AG, Dudea D, Berindan-Neagoe I. Current Insights into Oral Cancer Epigenetics. Int J Mol Sci 2018;19:E670. [PMID: 29495520 DOI: 10.3390/ijms19030670] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
245 Hu T, Shen H, Li J, Yang P, Gu Q, Fu Z. RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells. J Cell Physiol 2020;235:8319-33. [PMID: 32239691 DOI: 10.1002/jcp.29676] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
246 Xu X, Liu Y, Li Y, Chen H, Zhang Y, Liu J, Deng S, Zheng Y, Sun X, Wang J, Chen T, Huang M, Ke Y. Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway. J Exp Clin Cancer Res 2021;40:16. [PMID: 33407703 DOI: 10.1186/s13046-020-01810-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
247 Nobili L, Ronchetti D, Agnelli L, Taiana E, Vinci C, Neri A. Long Non-Coding RNAs in Multiple Myeloma. Genes (Basel) 2018;9:E69. [PMID: 29389884 DOI: 10.3390/genes9020069] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
248 Braicu C, Raduly L, Morar-Bolba G, Cojocneanu R, Jurj A, Pop LA, Pileczki V, Ciocan C, Moldovan A, Irimie A, Eniu A, Achimas-Cadariu P, Paradiso A, Berindan-Neagoe I. Aberrant miRNAs expressed in HER-2 negative breast cancers patient. J Exp Clin Cancer Res 2018;37:257. [PMID: 30342533 DOI: 10.1186/s13046-018-0920-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 6.5] [Reference Citation Analysis]
249 Shah MY, Ferrajoli A, Sood AK, Lopez-Berestein G, Calin GA. microRNA Therapeutics in Cancer - An Emerging Concept. EBioMedicine 2016;12:34-42. [PMID: 27720213 DOI: 10.1016/j.ebiom.2016.09.017] [Cited by in Crossref: 223] [Cited by in F6Publishing: 230] [Article Influence: 37.2] [Reference Citation Analysis]
250 Wu Y, Yang L, Zhao J, Li C, Nie J, Liu F, Zhuo C, Zheng Y, Li B, Wang Z, Xu Y. Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer. Mol Cancer. 2015;14:191. [PMID: 26552600 DOI: 10.1186/s12943-015-0455-5] [Cited by in Crossref: 79] [Cited by in F6Publishing: 87] [Article Influence: 11.3] [Reference Citation Analysis]
251 Pop-Bica C, Gulei D, Cojocneanu-Petric R, Braicu C, Petrut B, Berindan-Neagoe I. Understanding the Role of Non-Coding RNAs in Bladder Cancer: From Dark Matter to Valuable Therapeutic Targets. Int J Mol Sci 2017;18:E1514. [PMID: 28703782 DOI: 10.3390/ijms18071514] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 8.2] [Reference Citation Analysis]
252 Zhang W, Wan B, Liu B, Wu S, Zhao L. Clinical significance of miR-372 and miR-495 in acute myeloid leukemia. Oncol Lett 2020;20:1938-44. [PMID: 32724438 DOI: 10.3892/ol.2020.11748] [Reference Citation Analysis]
253 Lei Y, Junxin C, Yongcan H, Xiaoguang L, Binsheng Y. Role of microRNAs in the crosstalk between osteosarcoma cells and the tumour microenvironment. J Bone Oncol 2020;25:100322. [PMID: 33083216 DOI: 10.1016/j.jbo.2020.100322] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
254 Xie K, Ma H, Liang C, Wang C, Qin N, Shen W, Gu Y, Yan C, Zhang K, Dai N, Zhu M, Wu S, Wang H, Dai J, Jin G, Shen H, Hu Z. A functional variant in miR-155 regulation region contributes to lung cancer risk and survival. Oncotarget 2015;6:42781-92. [PMID: 26543233 DOI: 10.18632/oncotarget.5840] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
255 Gigante M, Pontrelli P, Herr W, Gigante M, D'Avenia M, Zaza G, Cavalcanti E, Accetturo M, Lucarelli G, Carrieri G, Battaglia M, Storkus WJ, Gesualdo L, Ranieri E. miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction. J Transl Med 2016;14:84. [PMID: 27063186 DOI: 10.1186/s12967-016-0841-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
256 Zong M, Liu Y, Zhang K, J Y, Chen L. The effects of miR-429 on cell migration and invasion by targeting Slug in esophageal squamous cell carcinoma. Pathol Res Pract. 2019;215:152526. [PMID: 31324391 DOI: 10.1016/j.prp.2019.152526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
257 Lv Y, Huang Z, Lin Y, Fang Y, Chen Z, Pan L, Zhang Y, Xu Z. MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma. Oncoimmunology. 2019;8:e1629260. [PMID: 31646073 DOI: 10.1080/2162402x.2019.1629260] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
258 Sur D, Burz C, Sabarimurugan S, Irimie A. Diagnostic and Prognostic Significance of MiR-150 in Colorectal Cancer: A Systematic Review and Meta-Analysis. J Pers Med 2020;10:E99. [PMID: 32847098 DOI: 10.3390/jpm10030099] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
259 Soekojo CY, de Mel S, Ooi M, Yan B, Chng WJ. Potential Clinical Application of Genomics in Multiple Myeloma. Int J Mol Sci 2018;19:E1721. [PMID: 29890777 DOI: 10.3390/ijms19061721] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
260 Boisen MK, Dehlendorff C, Linnemann D, Schultz NA, Jensen BV, Høgdall EV, Johansen JS. MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability. BMC Cancer 2015;15:1024. [PMID: 26714641 DOI: 10.1186/s12885-015-2030-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
261 Azimzadeh M, Rahaie M, Nasirizadeh N, Naderi-manesh H. Application of Oracet Blue in a novel and sensitive electrochemical biosensor for the detection of microRNA. Anal Methods 2015;7:9495-503. [DOI: 10.1039/c5ay01848j] [Cited by in Crossref: 24] [Article Influence: 3.4] [Reference Citation Analysis]
262 Preethi KA, Lakshmanan G, Sekar D. Antagomir technology in the treatment of different types of cancer. Epigenomics 2021;13:481-4. [PMID: 33719531 DOI: 10.2217/epi-2020-0439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
263 Gulei D, Mehterov N, Nabavi SM, Atanasov AG, Berindan-neagoe I. Targeting ncRNAs by plant secondary metabolites: The ncRNAs game in the balance towards malignancy inhibition. Biotechnology Advances 2018;36:1779-99. [DOI: 10.1016/j.biotechadv.2017.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
264 Liang H, Hu C, Lin X, He Z, Lin Z, Dai J. MiR-548d-3p Promotes Gastric Cancer by Targeting RSK4. Cancer Manag Res 2020;12:13325-37. [PMID: 33380838 DOI: 10.2147/CMAR.S278691] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
265 Van Roosbroeck K, Calin GA. MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies? Semin Oncol 2016;43:209-14. [PMID: 27040698 DOI: 10.1053/j.seminoncol.2016.02.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
266 You A, Rao G, Wang J, Li J, Zhang Y, Gu J, Ge X, Zhang K, Gao X, Wu X, Cheng L, Zhu M, Wang D. MiR-433-3p restrains the proliferation, migration and invasion of glioma cells via targeting SMC4. Brain Res 2021;1767:147563. [PMID: 34147470 DOI: 10.1016/j.brainres.2021.147563] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
267 Kong P, Zhu X, Geng Q, Xia L, Sun X, Chen Y, Li W, Zhou Z, Zhan Y, Xu D. The microRNA-423-3p-Bim Axis Promotes Cancer Progression and Activates Oncogenic Autophagy in Gastric Cancer. Mol Ther 2017;25:1027-37. [PMID: 28254439 DOI: 10.1016/j.ymthe.2017.01.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
268 Zhu LR, Yuan RX, Xia XB, Wang Y, Zhu YM, Fi L, Li J. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion. Cancer Biomark 2021. [PMID: 34366325 DOI: 10.3233/CBM-210090] [Reference Citation Analysis]
269 Shi X, Valizadeh A, Mir SM, Asemi Z, Karimian A, Majidina M, Safa A, Yosefi B. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells. European Journal of Pharmacology 2020;880:173138. [DOI: 10.1016/j.ejphar.2020.173138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 4.5] [Reference Citation Analysis]
270 Li J, Jin B, Wang T, Li W, Wang Z, Zhang H, Song Y, Li N. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma. Cancer Biomark 2019;26:501-12. [PMID: 31658041 DOI: 10.3233/CBM-181970] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
271 Calin GA, Vazquez F. Welcome to the New Journal Non-Coding RNA! Noncoding RNA 2014;1:1-3. [PMID: 33353258 DOI: 10.3390/ncrna1010001] [Reference Citation Analysis]
272 Jia Q, Xie B, Zhao Z, Huang L, Wei G, Ni T. Lung cancer cells expressing a shortened CDK16 3'UTR escape senescence through impaired miR-485-5p targeting. Mol Oncol 2021. [PMID: 34687270 DOI: 10.1002/1878-0261.13125] [Reference Citation Analysis]
273 Zheng D, Zang Y, Xu H, Wang Y, Cao X, Wang T, Pan M, Shi J, Li X. MicroRNA-214 promotes the calcification of human aortic valve interstitial cells through the acceleration of inflammatory reactions with activated MyD88/NF-κB signaling. Clin Res Cardiol 2019;108:691-702. [PMID: 30519780 DOI: 10.1007/s00392-018-1398-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
274 Guo W, Zhao L, Wei G, Liu P, Zhang Y, Fu L. Circ_0015756 Aggravates Hepatocellular Carcinoma Development by Regulating FGFR1 via Sponging miR-610. Cancer Manag Res 2020;12:7383-94. [PMID: 32884351 DOI: 10.2147/CMAR.S262231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
275 Deng B, Wang M, Liu Z. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer. Medicine (Baltimore) 2020;99:e22261. [PMID: 32957376 DOI: 10.1097/MD.0000000000022261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
276 Moazeni-Roodi A, Bahari G, Taheri M, Ansari H, Hashemi M. Association between miR-218 rs11134527 polymorphism and risk of selected types of cancer in Asian population: An updated meta-analysis of case-control studies. Gene 2018;678:370-6. [PMID: 30120974 DOI: 10.1016/j.gene.2018.08.053] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
277 Li G, Yang F, Xu H, Yue Z, Fang X, Liu J. MicroRNA-708 is downregulated in hepatocellular carcinoma and suppresses tumor invasion and migration. Biomedicine & Pharmacotherapy 2015;73:154-9. [DOI: 10.1016/j.biopha.2015.05.010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
278 Cortez MA, Anfossi S, Ramapriyan R, Menon H, Atalar SC, Aliru M, Welsh J, Calin GA. Role of miRNAs in immune responses and immunotherapy in cancer. Genes Chromosomes Cancer 2019;58:244-53. [PMID: 30578699 DOI: 10.1002/gcc.22725] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 13.0] [Reference Citation Analysis]
279 Andersen GB, Tost J. Circulating miRNAs as Biomarker in Cancer. Recent Results Cancer Res 2020;215:277-98. [PMID: 31605235 DOI: 10.1007/978-3-030-26439-0_15] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
280 Krishnan P, Damaraju S. The Challenges and Opportunities in the Clinical Application of Noncoding RNAs: The Road Map for miRNAs and piRNAs in Cancer Diagnostics and Prognostics. Int J Genomics 2018;2018:5848046. [PMID: 29854719 DOI: 10.1155/2018/5848046] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
281 Anfossi S, Fu X, Nagvekar R, Calin GA. MicroRNAs, Regulatory Messengers Inside and Outside Cancer Cells. Adv Exp Med Biol 2018;1056:87-108. [PMID: 29754176 DOI: 10.1007/978-3-319-74470-4_6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
282 Browne G, Dragon JA, Hong D, Messier TL, Gordon JA, Farina NH, Boyd JR, VanOudenhove JJ, Perez AW, Zaidi SK, Stein JL, Stein GS, Lian JB. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells. Tumour Biol 2016;37:8825-39. [PMID: 26749280 DOI: 10.1007/s13277-015-4710-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
283 de Melo Maia B, Ling H, Monroig P, Ciccone M, Soares FA, Calin GA, Rocha RM. Design of a miRNA sponge for the miR-17 miRNA family as a therapeutic strategy against vulvar carcinoma. Mol Cell Probes 2015;29:420-6. [PMID: 26297962 DOI: 10.1016/j.mcp.2015.08.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
284 Johansen JS, Calatayud D, Albieri V, Schultz NA, Dehlendorff C, Werner J, Jensen BV, Pfeiffer P, Bojesen SE, Giese N. The potential diagnostic value of serum microRNA signature in patients with pancreatic cancer. Int J Cancer. 2016;139:2312-2324. [PMID: 27464352 DOI: 10.1002/ijc.30291] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
285 Wang N, Zhu C, Xu Y, Qian W, Zheng M. Negative Regulation of PTEN by MicroRNA-221 and Its Association with Drug Resistance and Cellular Senescence in Lung Cancer Cells. Biomed Res Int 2018;2018:7908950. [PMID: 29876362 DOI: 10.1155/2018/7908950] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
286 Nicolè L, Cappellesso R, Sanavia T, Guzzardo V, Fassina A. MiR-21 over-expression and Programmed Cell Death 4 down-regulation features malignant pleural mesothelioma. Oncotarget 2018;9:17300-8. [PMID: 29707109 DOI: 10.18632/oncotarget.24644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
287 Tang CY, Man XF, Guo Y, Tang HN, Tang J, Zhou CL, Tan SW, Wang M, Zhou HD. IRS-2 Partially Compensates for the Insulin Signal Defects in IRS-1-/- Mice Mediated by miR-33. Mol Cells 2017;40:123-32. [PMID: 28190325 DOI: 10.14348/molcells.2017.2228] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
288 Venturutti L, Cordo Russo RI, Rivas MA, Mercogliano MF, Izzo F, Oakley RH, Pereyra MG, De Martino M, Proietti CJ, Yankilevich P, Roa JC, Guzmán P, Cortese E, Allemand DH, Huang TH, Charreau EH, Cidlowski JA, Schillaci R, Elizalde PV. MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1. Oncogene 2016;35:6189-202. [PMID: 27157613 DOI: 10.1038/onc.2016.151] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 8.2] [Reference Citation Analysis]
289 Mashayekhi S, Saeidi Saedi H, Salehi Z, Soltanipour S, Mirzajani E. Effects of miR-27a, miR-196a2 and miR-146a polymorphisms on the risk of breast cancer. British Journal of Biomedical Science 2018;75:76-81. [DOI: 10.1080/09674845.2017.1399572] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
290 Lu Q, Xu L, Li C, Yuan Y, Huang S, Chen H. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer. Tumour Biol 2016;37:14605-14. [PMID: 27619677 DOI: 10.1007/s13277-016-5320-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
291 Targhazeh N, Yousefi B, Asghari S, Mohammadnejhad R, Mansouri P, Valizadeh A. MiR-622 acts as a tumor suppressor to induce cell apoptosis and inhibit metastasis in human prostate cancer. Andrologia 2021;:e14174. [PMID: 34231241 DOI: 10.1111/and.14174] [Reference Citation Analysis]
292 Bullock MD, Silva AM, Kanlikilicer-Unaldi P, Filant J, Rashed MH, Sood AK, Lopez-Berestein G, Calin GA. Exosomal Non-Coding RNAs: Diagnostic, Prognostic and Therapeutic Applications in Cancer. Noncoding RNA 2015;1:53-68. [PMID: 29861415 DOI: 10.3390/ncrna1010053] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
293 Cai Q, Zhao A, Ren L, Chen J, Liao K, Wang Z, Zhang W. MicroRNA-1291 mediates cell proliferation and tumorigenesis by downregulating MED1 in prostate cancer. Oncol Lett 2019;17:3253-60. [PMID: 30867757 DOI: 10.3892/ol.2019.9980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
294 Chen H, Mao M, Jiang J, Zhu D, Li P. Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression. Onco Targets Ther 2019;12:3869-79. [PMID: 31190886 DOI: 10.2147/OTT.S207938] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 10.3] [Reference Citation Analysis]
295 Li Z, Zhang Q, Wu Y, Hu F, Gu L, Chen T, Wang W. lncRNA Malat1 modulates the maturation process, cytokine secretion and apoptosis in airway epithelial cell-conditioned dendritic cells. Exp Ther Med 2018;16:3951-8. [PMID: 30344673 DOI: 10.3892/etm.2018.6687] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
296 Reichl P, Mikulits W. Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review). Oncol Rep. 2016;36:613-625. [PMID: 27278244 DOI: 10.3892/or.2016.4842] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
297 Hu C, Li Y, Pan D, Wang J, Zhu L, Lin Y, Zhu S, Pan W. A Schistosoma japonicum MicroRNA Exerts Antitumor Effects Through Inhibition of Both Cell Migration and Angiogenesis by Targeting PGAM1. Front Oncol 2021;11:652395. [PMID: 34221971 DOI: 10.3389/fonc.2021.652395] [Reference Citation Analysis]
298 Braicu C, Gulei D, Cojocneanu R, Raduly L, Jurj A, Knutsen E, Calin GA, Berindan-Neagoe I. miR-181a/b therapy in lung cancer: reality or myth? Mol Oncol 2019;13:9-25. [PMID: 30548184 DOI: 10.1002/1878-0261.12420] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
299 Giunti L, Da Ros M, De Gregorio V, Magi A, Landini S, Mazzinghi B, Buccoliero AM, Genitori L, Giglio S, Sardi I. A microRNA profile of pediatric glioblastoma: The role of NUCKS1 upregulation. Mol Clin Oncol 2019;10:331-8. [PMID: 30847170 DOI: 10.3892/mco.2019.1795] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
300 Zuo Z, Jiang Y, Zeng S, Li Y, Fan J, Guo Y, Tao H. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: A meta-analysis. Pathol Res Pract 2020;216:153130. [PMID: 32853954 DOI: 10.1016/j.prp.2020.153130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
301 Wu W, Wu D, Yan W, Wang Y, You J, Wan X, Xi D, Luo X, Han M, Ning Q. Interferon-Induced Macrophage-Derived Exosomes Mediate Antiviral Activity Against Hepatitis B Virus Through miR-574-5p. J Infect Dis 2021;223:686-98. [PMID: 32663850 DOI: 10.1093/infdis/jiaa399] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
302 Sur DG, Colceriu M, Sur G, Aldea C, Silaghi C, Samasca G, Lupan I, Căinap C, Burz C, Irimie A. MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer. Expert Rev Proteomics 2019;16:851-6. [PMID: 31446809 DOI: 10.1080/14789450.2019.1659732] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
303 Zhang F, Qiao S. Research Progress on the Relationship Between Inflammation and Colorectal Cancer. Ann Gastroenterol Surg. [DOI: 10.1002/ags3.12517] [Reference Citation Analysis]
304 Zanoaga O, Jurj A, Raduly L, Cojocneanu-Petric R, Fuentes-Mattei E, Wu O, Braicu C, Gherman CD, Berindan-Neagoe I. Implications of dietary ω-3 and ω-6 polyunsaturated fatty acids in breast cancer. Exp Ther Med 2018;15:1167-76. [PMID: 29434704 DOI: 10.3892/etm.2017.5515] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
305 Ruan J, Lou S, Dai Q, Mao D, Ji J, Sun X. Tumor suppressor miR-181c attenuates proliferation, invasion, and self-renewal abilities in glioblastoma. Neuroreport 2015;26:66-73. [PMID: 25494473 DOI: 10.1097/WNR.0000000000000302] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
306 Chira S, Gulei D, Hajitou A, Zimta AA, Cordelier P, Berindan-Neagoe I. CRISPR/Cas9: Transcending the Reality of Genome Editing. Mol Ther Nucleic Acids 2017;7:211-22. [PMID: 28624197 DOI: 10.1016/j.omtn.2017.04.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 10.2] [Reference Citation Analysis]
307 Zhao Q, Chen S, Zhu Z, Yu L, Ren Y, Jiang M, Weng J, Li B. miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2. Cell Death Dis 2018;9:1157. [PMID: 30464258 DOI: 10.1038/s41419-018-1182-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
308 Cappellesso R, Nicolè L, Caroccia B, Guzzardo V, Ventura L, Fassan M, Fassina A. Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology: miRNA Profiling in Pleural Effusions. Cancer Cytopathology 2016;124:28-37. [DOI: 10.1002/cncy.21646] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]